Package 25021-215-99

{"route": ["INTRAVENOUS"], "spl_id": "223c5d8d-c064-4a0a-8490-b1c4aa0e706d", "openfda": {"nui": ["N0000000233", "N0000175595"], "unii": ["U3P01618RT"], "rxcui": ["239177"], "spl_set_id": ["37e35e8c-5d51-413b-a3a0-b72a18caaf65"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Sagent Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (25021-215-98)  / 50 mL in 1 BOTTLE", "package_ndc": "25021-215-98", "marketing_start_date": "20160915"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (25021-215-99)  / 100 mL in 1 BOTTLE", "package_ndc": "25021-215-99", "marketing_start_date": "20160915"}], "brand_name": "fluorouracil", "product_id": "25021-215_223c5d8d-c064-4a0a-8490-b1c4aa0e706d", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "25021-215", "generic_name": "fluorouracil", "labeler_name": "Sagent Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "fluorouracil", "active_ingredients": [{"name": "FLUOROURACIL", "strength": "50 mg/mL"}], "application_number": "ANDA203609", "marketing_category": "ANDA", "marketing_start_date": "20160915", "listing_expiration_date": "20271231"}